Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Insulin resistance: a key therapeutic target for cardiovascular risk reduction in obese patients?
Shakun Karki1, Doan Tm Ngo1, Sherman J Bigornia1
1a Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA.
Abstract:
The global obesity epidemic has emerged as one of the most important health care problems worldwide. Insulin resistance represents a prevalent pathophysiological abnormality that underlies mechanisms of cardiometabolic disease associated with obesity. Increasing basic, animal, and clinical data support a mechanistic link between insulin resistance and vascular dysfunction, and suggest that improving insulin sensitivity may represent a therapeutic target for combating atherosclerosis and cardiovascular disease. As clinical studies suggest that insulin resistance may play a key role in the cardiovascular benefit achieved with weight loss intervention, we will discuss our clinical perspective and provide evidence that obese individuals with hyperinsulinemia may derive the greatest improvement in vascular function with weight reduction. Lastly, we will address several important unanswered questions in the field that are likely to drive future clinical investigation.
Insights
Obesity and insulin resistance contribute to cardiovascular disease. Weight loss interventions may improve vascular function, especially in obese individuals with hyperinsulinemia, highlighting insulin sensitivity as a therapeutic target.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Disease
Background:
- The global obesity epidemic is a major health concern.
- Insulin resistance is a key factor in obesity-related cardiometabolic diseases.
- A link exists between insulin resistance and vascular dysfunction.
Purpose of the Study:
- To explore the connection between insulin resistance and vascular dysfunction in obesity.
- To examine the role of insulin sensitivity as a therapeutic target for atherosclerosis and cardiovascular disease.
- To present evidence that weight loss improves vascular function in obese individuals with hyperinsulinemia.
Main Methods:
- Review of basic, animal, and clinical data.
- Analysis of clinical studies on weight loss interventions.
- Clinical perspective on hyperinsulinemia and vascular function.
Main Results:
- Insulin resistance is linked to vascular dysfunction in obese individuals.
- Improving insulin sensitivity may combat atherosclerosis and cardiovascular disease.
- Obese individuals with hyperinsulinemia show greatest vascular function improvement with weight reduction.
Conclusions:
- Insulin resistance is a critical factor in obesity-related cardiovascular risks.
- Weight loss interventions show promise for improving vascular health in obese populations.
- Targeting insulin sensitivity offers a potential therapeutic strategy for cardiovascular disease prevention.
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Cardiovascular Drugs: Classification based on Therapeutic Indications
Obesity
Key Techniques in Microbiology

